Nature Medicine, Published online: 21 July 2025; doi:10.1038/s41591-025-03895-1
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Nature Medicine, Published online: 21 July 2025; doi:10.1038/s41591-025-03895-1
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
SoCalTreatmentServices.com Reaffirms Commitment to Comprehensive Addiction &
New Colorado Bill Protects Beavers to Reduce
Renewable energy – powering a safer and
Humann and Texas Athletics Bring Heart Health
Sorry, the comment form is closed at this time.
